Immunome (IMNM) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free IMNM Stock Alerts $15.81 +0.48 (+3.13%) (As of 11:33 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImmunome to Present at 2024 Bank of America Healthcare Conferencebusinesswire.com - May 8 at 8:00 AMImmunome Appoints Kinney Horn as Chief Business Officerbusinesswire.com - May 2 at 8:00 AMImmunome (NASDAQ:IMNM) Now Covered by Analysts at JPMorgan Chase & Co.americanbankingnews.com - May 1 at 3:50 AMImmunome (NASDAQ:IMNM) Shares Gap Up to $13.82marketbeat.com - April 30 at 1:06 PMImmunome Appoints Sandra M. Swain to Board of Directorsbusinesswire.com - April 25 at 8:26 AM61,346 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by Cerity Partners LLCmarketbeat.com - April 24 at 4:43 AMImmunome (NASDAQ:IMNM) Shares Gap Up to $15.48marketbeat.com - April 22 at 12:49 PMImmunome, Inc. (IMNM)finance.yahoo.com - April 19 at 1:00 AMImmunome (IMNM) Price Target Increased by 8.72% to 36.04msn.com - April 17 at 1:59 PMGuggenheim Initiates Coverage of Immunome (IMNM) with Buy Recommendationmsn.com - April 16 at 1:11 PMEmfo LLC Buys Shares of 59,165 Immunome, Inc. (NASDAQ:IMNM)marketbeat.com - April 15 at 6:38 PMImmunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Buy" by Brokeragesmarketbeat.com - April 15 at 8:23 AMImmunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meetingbusinesswire.com - April 5 at 8:00 AMImmunome (NASDAQ:IMNM) Trading Down 4.5%marketbeat.com - April 4 at 6:20 PMQ1 2024 EPS Estimates for Immunome, Inc. (NASDAQ:IMNM) Reduced by Wedbushmarketbeat.com - April 4 at 8:32 AMWedbush Weighs in on Immunome, Inc.'s Q1 2025 Earnings (NASDAQ:IMNM)marketbeat.com - April 3 at 6:30 AMImmunome (NASDAQ:IMNM) Given New $33.00 Price Target at Wedbushmarketbeat.com - April 1 at 8:30 AMLeerink Partnrs Weighs in on Immunome, Inc.'s Q1 2024 Earnings (NASDAQ:IMNM)marketbeat.com - March 29 at 8:16 AMIMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 29 at 2:01 AMTD Cowen Reaffirms Their Buy Rating on Immunome (IMNM)markets.businessinsider.com - March 28 at 11:33 PMImmunome (NASDAQ:IMNM) Shares Down 3.7% marketbeat.com - March 28 at 4:33 PMImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assetsbusinesswire.com - March 28 at 4:06 PMImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assetsbusinesswire.com - March 28 at 4:02 PMImmunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayalafinance.yahoo.com - March 27 at 1:08 AMImmunome (NASDAQ:IMNM) Shares Up 5.3%marketbeat.com - March 26 at 4:46 PMImmunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutionsfinance.yahoo.com - March 22 at 10:45 AMImmunome (NASDAQ:IMNM) Trading Down 5%marketbeat.com - March 20 at 12:46 PMImmunome (NASDAQ:IMNM) Trading 7.3% Higher marketbeat.com - March 19 at 4:48 PMArrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapiesmsn.com - March 18 at 10:37 AMArrayjet's ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapiesbusinesswire.com - March 18 at 5:44 AMImmunome (NASDAQ:IMNM) Shares Down 6.3% marketbeat.com - March 11 at 3:17 PMImmunome (NASDAQ:IMNM) Sets New 1-Year High at $29.40marketbeat.com - March 7 at 10:51 AMImmunome to Participate in the Leerink Partners Global Biopharma Conferencebusinesswire.com - March 7 at 8:00 AM49,712 Shares in Immunome, Inc. (NASDAQ:IMNM) Purchased by Acadian Asset Management LLCmarketbeat.com - March 2 at 5:28 AMImmunome to Participate in the TD Cowen 44th Annual Healthcare Conferencebusinesswire.com - March 1 at 8:00 AMBiotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?msn.com - February 28 at 2:47 PMImmunome (NASDAQ:IMNM) Hits New 1-Year High at $27.56marketbeat.com - February 28 at 11:29 AMImmunome (IMNM) Price Target Increased by 179.17% to 34.17msn.com - February 24 at 8:51 AMImmunome Stock (NASDAQ:IMNM), Short Interest Reportbenzinga.com - February 22 at 10:13 AMImmunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumorsfinance.yahoo.com - February 20 at 10:40 AMImmunome Recognizes Ayala Pharmaceuticals' Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumorsbusinesswire.com - February 20 at 8:15 AMIMNM Apr 2024 30.000 callfinance.yahoo.com - February 19 at 12:54 AMIMNM Mar 2024 10.000 putfinance.yahoo.com - February 19 at 12:54 AMIMNM Jul 2024 25.000 putca.finance.yahoo.com - February 17 at 11:26 PMIMNM Mar 2024 20.000 putca.finance.yahoo.com - February 17 at 11:26 PMIMNM Apr 2024 12.500 putfinance.yahoo.com - February 17 at 6:26 PMIMNM Apr 2024 7.500 callfinance.yahoo.com - February 17 at 1:26 PMIMNM Mar 2024 22.500 putfinance.yahoo.com - February 17 at 1:26 PMImmunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - February 16 at 5:09 PMImmunome Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Sharesbusinesswire.com - February 16 at 4:05 PM Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results. Don't miss out on the "next Ozempic" >>> IMNM Media Mentions By Week IMNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼0.660.38▲Average Medical News Sentiment IMNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼22▲IMNM Articles Average Week Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SPRY News Today SAGE News Today OPK News Today ALXO News Today TNGX News Today ELVN News Today ETNB News Today ARQT News Today ZNTL News Today TYRA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
